Radius Health Inc logo

RDUS - Radius Health Inc News Story

$10.95 0.0  0.4%

Last Trade - 25/09/20

Mid Cap
Market Cap £399.3m
Enterprise Value £468.7m
Revenue £157.3m
Position in Universe 2886th / 6417

BUZZ-Radius Health: Patch version of osteoporosis drug could drive stock - Leerink

Thu 29th March, 2018 1:45pm
** Drugmaker's shares  RDUS.O  up 3 pct at $35.40 premarket
    ** Brokerage Leerink starts coverage with "outperform" and
$53 PT 
    ** RDUS's Tymlos, an injection that rebuilds bone density in
postmenopausal osteoporosis patients, could earn peak U.S. sales
of $500 mln -600 mln a year - Leerink analyst Geoffrey Porges 
    ** Despite lower price compared to Eli Lilly's  LLY.N  rival
drug, Tymlos is unlikely to gain dominant market share, Porges
says, adding it is reasonable to expect RDUS to split the market
by 2020 with Lilly
    ** However, a patch version of Tymlos that is currently
being tested will likely "significantly increase" share gains,
even with a relatively low probability of success, Porges adds
    ** 4 of 8 brokerages rate the stock "buy" or higher, 4
"hold"; their median PT is $47

 (Reporting by Tamara Mathias in Bengaluru)
 ((Tamara.Mathias@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 1208; Reuters Messaging:
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.